Thursday afternoon's analyst upgrades and downgrades included Amazon, Bank of America, BioNTech, Chipotle, Disney and more.
Here are more morning analyst research calls made before Tuesday's opening bell.
Friday's top analyst upgrades, downgrades and initiations include BP, Netflix, Otonomy, Salesforce.com, Total and VeriFone Systems.
Shots were fired again on the Horizon Pharma and DepoMed merger front. However it was DepoMed this time pushing back.
If we look at what Horizon is paying, it doesn’t necessarily add up, using the numbers from this year, but if we look at more data the picture becomes clearer.
Tuesday's top analyst upgrades and downgrades include Brocade Communications, IAC/InterActiveCorp, Nabors Industries, Priceline, Teva Pharmaceutical and Yamana Gold.
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal,...
The S&P 500 and Dow are pushing new highs as 2016 comes to a close. While the post-election tailwind has been incredibly strong, there are still companies holding back this rally.
Wednesday afternoon's top analyst upgrades and downgrades included AeroVironment, AutoZone, BigCommerce, NXP Semiconductors, Roblox, Stitch Fix and more.
Tuesday’s top analyst upgrades and downgrades included Boeing, Boston Scientific, ChargePoint, Deere, Foot Locker, Horizon Therapeutics, Nu, Ross Stores, Salesforce, United Parcel Service, VF,...
Friday's top analyst upgrades and downgrades included AbbVie, Amazon.com, APA, CF Industries, Costco Wholesale, eBay, Etsy, GoDaddy, Intercontinental Exchange, Lululemon Athletica, Match, MetLife,...
A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical issues muddy the waters.
Wednesday's top analyst upgrades and downgrades included Accenture, Bridgebio Pharma, Chesapeake Energy, eBay, Hewlett Packard Enterprise, Huntsman, New York Community Bancorp, Nucor, Oracle, PBF...